Arrowhead Pharmaceuticals Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ARWR Nasdaq 2834 http://arrowheadpharma.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arrowhead Pharmaceuticals Inc

What Kind Of Shareholders Hold The Majority In Arrowhead Pharmaceuticals, Inc.'s (NASDAQ:ARWR) Shares? - Jul 9th, 2020 12:19 pm
Arrowhead Pharmaceuticals to Host Key Opinion Leader Webinar on ARO-ENaC for Treatment of Cystic Fibrosis - Jul 9th, 2020 11:30 am
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Third Quarter Results - Jul 8th, 2020 8:00 pm
Here's Why Arrowhead Pharmaceuticals Stock Jumped 34% in June - Jul 8th, 2020 2:13 pm
Is Arrowhead Pharmaceuticals Inc. (ARWR) A Good Stock To Buy? - Jun 17th, 2020 1:46 am
ARWR: Multiple ‘Shots on Goal’ for RNAi Platform… - Jun 16th, 2020 1:30 pm
Will Johnson & Johnson Acquire Arrowhead Pharmaceuticals? - Jun 2nd, 2020 4:35 pm
Edited Transcript of ARWR earnings conference call or presentation 7-May-20 8:30pm GMT - May 30th, 2020 10:35 pm
Arrowhead Pharmaceuticals to Participate in Upcoming June 2020 Conferences - May 28th, 2020 11:30 am
Is Arrowhead Pharmaceuticals a Buy? - May 24th, 2020 2:10 pm
Arrowhead Pharmaceuticals Is Likely to See a Trading Range Market Ahead - May 22nd, 2020 3:34 pm
Arrowhead Pharmaceuticals Reports Fiscal 2020 Second Quarter Results - May 7th, 2020 8:00 pm
Arrowhead Pharmaceuticals to Participate in Upcoming May 2020 Conferences - May 1st, 2020 8:00 pm
Arrowhead Pharmaceuticals Announces Retirement of COO Bruce Given - May 1st, 2020 8:00 pm
Is Arrowhead Pharmaceuticals Close to a Cure for HBV? - Apr 30th, 2020 11:52 am
Arrowhead Pharmaceuticals to Webcast Fiscal 2020 Second Quarter Results - Apr 22nd, 2020 11:30 am
Arrowhead Pharmaceuticals' (NASDAQ:ARWR) Incredible 2370% Share Price Run Shows What Is Possible With Stocks - Apr 20th, 2020 10:31 am
Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2a Study of ARO-ENaC for Treatment of Cystic Fibrosis - Apr 10th, 2020 11:30 am
Alnylam, Dicerna Join Forces to Take on Arrowhead - Apr 6th, 2020 10:26 pm
Former gene-silencing rivals bury the hatchet with new partnership - Apr 6th, 2020 2:30 pm